The CRISPR Dispute

February 22nd, 2017|

In the hotly patent war over the priority to the invention of the CRISPR-Cas9 system between two of the most powerful universities in the US, last week on 15 February 2017, judges at USPTO ruled in favor of the Broad Institute, MIT and declared that “there is no interference-in-fact” between the two parties. In other words that the Broad Institute will retain the exclusive rights to decide who is allowed to use this groundbreaking thereby dealing a blow to the University of California.